Fig 1.
Flow diagram for patient inclusion.
Table 1.
Patient demographics.
Table 2.
Cancer staging and pathologic features.
Fig 2.
Cumulative incidences of cancer progression and all-cause mortality between EA and non-EA groups.
No significant difference in cancer progression (Fig 2A and 2B) or overall mortality (Figs 2C and 2D) after surgery for stage IV colorectal cancer was noted when comparing EA with non-EA groups.
Table 3.
Univariate analysis of cancer progression and all-cause mortality.
Table 4.
Forward model selection for progression-free and overall survival.